Next Article in Journal
ECG Changes in Melanoma Patients Undergoing Cancer Therapy—Data from the ECoR Registry
Next Article in Special Issue
Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
Previous Article in Journal
Remission of Proteinuria May Protect against Progression to Chronic Kidney Disease in Pediatric-Onset IgA Nephropathy
Previous Article in Special Issue
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
Open AccessReview

New Antithrombotic Drugs in Acute Coronary Syndrome

1
Department of Cardiology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands
2
Department of Cardiology, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands
3
Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK
4
South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(7), 2059; https://doi.org/10.3390/jcm9072059
Received: 29 May 2020 / Revised: 25 June 2020 / Accepted: 27 June 2020 / Published: 30 June 2020
(This article belongs to the Special Issue Antithrombotic Treatment of Acute Coronary Syndrome)
In recent years, much progress has been made in the field of antithrombotic drugs in acute coronary syndrome (ACS) treatment, as reflected by the introduction of the more potent P2Y12-inhibitors prasugrel and ticagrelor, and novel forms of concomitant anticoagulation, such as fondaparinux and bivalirudin. However, despite substantial improvements in contemporary ACS treatment, there remains residual ischemic risk in this group and hence the need for even more effective antithrombotic drugs, while balancing antithrombotic efficacy against bleeding risk. This review discusses recently introduced and currently developed antiplatelet and anticoagulant drugs in ACS treatment. View Full-Text
Keywords: acute coronary syndrome; platelets; antithrombotic drugs acute coronary syndrome; platelets; antithrombotic drugs
Show Figures

Figure 1

MDPI and ACS Style

Zwart, B.; Parker, W.A.E.; Storey, R.F. New Antithrombotic Drugs in Acute Coronary Syndrome. J. Clin. Med. 2020, 9, 2059.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop